Why the study?
Does medication nonadherence increase the risk of recurrent stroke and mortality in patients after first-ever ischemic stroke?
Does medication nonadherence increase the risk of recurrent stroke and mortality in patients after first-ever ischemic stroke?
Medication nonadherence to antithrombotics and statins significantly increases the risk of recurrent stroke and mortality in patients with first-ever ischemic stroke.
Answers are grounded in this paper and cite their sources.
Supports adherence monitoring post-stroke; leaves open whether interventions reduce events in RCTs.
Poor adherence to antithrombotic and statin treatment increases the risk of recurrent stroke and mortality in patients after first-ever ischemic stroke. Further measures are needed to improve medication adherence among stroke survivors.
No takes yet. Share an insight, caveat, or question.
Yeo et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: